Why the study?
Does volanesorsen reduce triglyceride levels in patients with familial chylomicronemia syndrome?
Does volanesorsen reduce triglyceride levels in patients with familial chylomicronemia syndrome?
Volanesorsen effectively lowers triglyceride levels in patients with familial chylomicronemia syndrome, though it is associated with thrombocytopenia and injection-site reactions.
No takes yet. Share an insight, caveat, or question.
Supports volanesorsen for triglyceride control in familial chylomicronemia syndrome; confirms benefit in the primary RCT.
Witztum et al. (2019) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: